Epitranscriptomic dysregulation in neurodegenerative diseases and its implications for disease pathology and mechanisms
Neurochemistry International · 2025
DOI: 10.1016/j.neuint.2025.106037 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Neurochemistry International, 2025. Verfasst von Andrew M Shafik und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Human Genetics, School of Medicine, Emory University, Atlanta, GA, 30322, USA. Electronic address: ashafik@emory.edu. Hauptthemen laut MEDLINE: Neurodegenerative Diseases, Epigenesis, Genetic, Transcriptome, RNA Processing, Post-Transcriptional. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 113 Literaturangaben. Gefördert von: National Institute of Mental Health and Neurosciences, Alzheimer's Disease Research Center, University of Pittsburgh, Emory University Goizueta Alzheimer's Disease Research Center.
Abstract (Originalsprache)
RNA modifications, collectively referred to as the epitranscriptome, play a crucial role in regulating RNA metabolism, influencing key processes such as splicing, stability, localization, and translation. Increasing evidence now links dysregulation of the epitranscriptome to neurodegenerative diseases. In this review, we focus on four RNA modifications and their influence on neurodegenerative pathways, including synaptic function, neuroinflammatory signaling, and stress granule formation. These findings highlight the complex and multifaceted roles that RNA modifications play in neurodegeneration, emphasizing their emerging potential as biomarkers and therapeutic targets.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Human Genetics, School of Medicine, Emory University, Atlanta, GA, 30322, USA. Electronic address: ashafik@emory.edu.
- Department of Human Genetics, School of Medicine, Emory University, Atlanta, GA, 30322, USA.
Förderung
- National Institute of Mental Health and Neurosciences
- Alzheimer's Disease Research Center, University of Pittsburgh
- Emory University Goizueta Alzheimer's Disease Research Center
Zitieren
APA
Shafik, A. M., & Jin, P. (2025). Epitranscriptomic dysregulation in neurodegenerative diseases and its implications for disease pathology and mechanisms. Neurochemistry International. https://doi.org/10.1016/j.neuint.2025.106037
Vancouver
Shafik AM, Jin P. Epitranscriptomic dysregulation in neurodegenerative diseases and its implications for disease pathology and mechanisms. Neurochemistry International. 2025. doi:10.1016/j.neuint.2025.106037
BibTeX
@article{Shafik2025,
author = {Shafik, Andrew M and Jin, Peng},
title = {Epitranscriptomic dysregulation in neurodegenerative diseases and its implications for disease pathology and mechanisms},
journal = {Neurochemistry International},
year = {2025},
doi = {10.1016/j.neuint.2025.106037}
}
EUVIMED